SynthesisFrontiers in medicine2024

Pegbelfermin for reducing transaminase levels in patients with non-alcoholic steatohepatitis: a dose-response meta-analysis of randomized controlled trials.

Yangguang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.